A new method for identifying the pathogens involved in sepsis cases, which could help to select optimal therapeutics, is reported in Nature. The test has the potential to reduce the turnaround times normally associated with developing treatments for infections and may improve patient outcomes.

FREMONT, Calif., July 25, 2024 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announces that it has successfully achieved ISO 13485:2016 certification. This internationally recognized standard for quality management systems is specific to the medical devices industry and signifies Alamar Biosciences’ dedication to providing the highest quality products and services to its customers.

A paraplegic person carried the Olympic torch as part of the traditional relay using an exoskeleton developed by Wandercraft.

Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff and costly equipment, hindering its availability, especially in low-resource settings. New research suggests a different kind of test could be more streamlined without sacrificing performance

Cysoni-XT is a temporary cardiac pacemaker from Welsh medtech company Ceryx Medical which aims to boost cardiac performance by resynchronisation of the heart and lungs, a natural phenomenon known as Respiratory Sinus Arrythmia (RSA). The system has shown a remarkable ability to boost performance and induce cardiac repair mechanisms in subjects with heart failure.

Asensus Surgical (NYSE:ASXC) announced today that it received FDA 510(k) clearance for an expanded surgical robot indication.

Samsara Vision announced that it completed the first procedure with its SING IMT miniature telescope technology in China.

FREMONT, Calif., July 23, 2024 /PRNewswire/ — THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced that its TMINI® Miniature Robotic System (TMINI 1.1) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).